Definium Therapeutics Inc (DFTX)

Operating Expenses

$75.08M

Quarterly · Period ending: · USD

DFTX logo

DFTX Operating Expenses

Latest reported$75.08M
DFTX Quarterly Operating Expenses ($314.20K → $75.08M)
High-resolution chart · PNG

DFTX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Definium Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
75,077,000
59,220,000
47,578,000
45,669,000
40,903,000
32,159,000
32,462,000
24,792,000
24,458,000
21,677,000
22,205,000
21,616,000
29,184,000
20,862,000
13,900,000
16,983,000
16,943,000
18,505,000
17,558,000
17,227,000
45,220,000
13,848,000
33,030,000
7,484,000
5,887,000
4,237,000
1,617,496
165,699
129,882
124,547
219,464
465,484
239,887
164,963
216,890
413,615
280,280
314,199
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.